1 |
1.2 mg zgn-440 for injectable suspension |
- |
- |
- |
- |
193 [1] 193 💬 |
2 |
1.8 mg zgn-440 for injectable suspension |
- |
- |
- |
- |
193 [1] 193 💬 |
3 |
[azp-531] |
- |
- |
- |
- |
193 [1] 193 💬 |
4 |
Acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [16] 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
5 |
Acomplia |
- |
- |
- |
- |
193 [1] 193 💬 |
6 |
Acomplia 20 mg film-coated tablets |
- |
- |
- |
- |
193 [1] 193 💬 |
7 |
Acth |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [5] 13, 66, 145, 193, 222 💬 |
8 |
Air |
- |
- |
- |
- |
003 [7] 3 , 51, 58, 85, 97, 193, 299 💬 |
9 |
Anastrozole |
Anastrozole |
[1] D00960 D00960 💬 |
CYP19A1 [1] CYP19A1 💬 |
Metabolic pathways [3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
078 [3] 78, 86, 193 💬 |
10 |
Azp-531 |
- |
- |
- |
- |
193 [1] 193 💬 |
11 |
B. lactis b94 |
- |
- |
- |
- |
193 [1] 193 💬 |
12 |
Beloranib |
Beloranib |
- |
- |
- |
193 [1] 193 💬 |
13 |
Byetta |
- |
- |
- |
- |
006 [2] 6 , 193 💬 |
14 |
Cannabidiol |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [17] 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
15 |
Cannabidiol oral solution |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
140 [4] 140, 144, 145, 193 💬 |
16 |
Carbetocin |
Carbetocin |
[1] D07229 D07229 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
17 |
Cbdv |
Cannabidivarin |
- |
- |
- |
193 [1] 193 💬 |
18 |
Cbdv compound |
Cannabidivarin |
- |
- |
- |
193 [1] 193 💬 |
19 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
20 |
Choline |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [4] 93, 171, 193, 299 💬 |
21 |
Coenzyme q10 |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
002 [12] 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
22 |
D.3.2 product code where applicable13: |
- |
- |
- |
- |
193 [1] 193 💬 |
23 |
Dccr |
- |
- |
- |
- |
193 [1] 193 💬 |
24 |
Diazoxide |
Diazoxide |
[1] D00294 D00294 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
013 [2] 13, 193 💬 |
25 |
Diazoxide choline |
Choline |
[2] D00294 D00294, D07690 D07690 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 [1] 193 💬 |
26 |
Diazoxide choline controlled-release tablet |
Choline |
[2] D00294 D00294, D07690 D07690 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 [1] 193 💬 |
27 |
Eu/1/06/362/003: 5µg (1 pen) |
- |
- |
- |
- |
193 [1] 193 💬 |
28 |
Eutropin |
- |
- |
- |
- |
078 [2] 78, 193 💬 |
29 |
Exenatide |
Exenatide |
[1] D04121 D04121 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [4] 6 , 17, 193, 233 💬 |
30 |
Fe 992097 |
- |
- |
- |
- |
193 [1] 193 💬 |
31 |
Fluimucil |
- |
- |
- |
- |
085 [4] 85, 94, 193, 298 💬 |
32 |
Fluimucil (acetylcysteine) |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
193 [1] 193 💬 |
33 |
Genotonorm |
- |
- |
- |
- |
193 [1] 193 💬 |
34 |
Genotonorm miniquick 0,2 mg |
- |
- |
- |
- |
193 [1] 193 💬 |
35 |
Genotropin |
- |
- |
- |
- |
013 [4] 13, 78, 187, 193 💬 |
36 |
Genotropin (somatropin) is a growth hormone treatment. it is an exact copy of the natural growth hormone that our bodies make. the main difference is that genotropin is man-made. |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
193 [1] 193 💬 |
37 |
Glwl-01 |
- |
- |
- |
- |
193 [1] 193 💬 |
38 |
Growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [12] 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
39 |
Growth hormone (genotonorm® or omnitrope®) |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [2] 78, 193 💬 |
40 |
Guanfacine |
Guanfacine |
[2] D00606 D00606, D08031 D08031 💬 |
ADRA2A [1] ADRA2A 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
193 [1] 193 💬 |
41 |
Guanfacine extended release (gxr) |
Guanfacine |
[2] D00606 D00606, D08031 D08031 💬 |
ADRA2A [1] ADRA2A 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
193 [1] 193 💬 |
42 |
Human growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [4] 78, 187, 193, 265 💬 |
43 |
Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten |
- |
- |
- |
- |
193 [1] 193 💬 |
44 |
Inn not yet proposed |
- |
- |
- |
- |
193 [1] 193 💬 |
45 |
Intranasal carbetocin dose 1 |
Carbetocin |
[1] D07229 D07229 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
46 |
Intranasal carbetocin dose 2 |
Carbetocin |
[1] D07229 D07229 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
47 |
Intranasal oxytocin |
Oxytocin |
[1] D00089 D00089 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
127 [2] 127, 193 💬 |
48 |
Intranasal oxytocin (in-oxt) |
Oxytocin |
[1] D00089 D00089 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
49 |
Liraglutide |
Liraglutide |
[1] D06404 D06404 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [3] 6 , 75, 193 💬 |
50 |
Livoletide |
Livoletide |
- |
- |
- |
193 [1] 193 💬 |
51 |
Medical air |
Medical air |
- |
- |
- |
085 [3] 85, 86, 193 💬 |
52 |
Medical air vs oxygen |
Medical air |
[1] D00003 D00003 💬 |
- |
- |
193 [1] 193 💬 |
53 |
Metoprolol |
Metoprolol |
[3] D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [6] 17, 57, 58, 113, 193, 226 💬 |
54 |
Metoprolol succinate |
Metoprolol |
[3] D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 [4] 57, 58, 113, 193 💬 |
55 |
Metoprololsuccinat orion 25mg |
- |
- |
- |
- |
193 [1] 193 💬 |
56 |
Metoprololsuccinat ”orion” 25mg |
- |
- |
- |
- |
193 [1] 193 💬 |
57 |
Metyrapone |
Metyrapone |
[2] D00410 D00410, D05019 D05019 💬 |
CYP11B1 [1] CYP11B1 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
075 [2] 75, 193 💬 |
58 |
Norditropin simplexx |
- |
- |
- |
- |
003 [4] 3 , 78, 193, 195 💬 |
59 |
Nutropin aq |
- |
- |
- |
- |
078 [4] 78, 134, 193, 299 💬 |
60 |
Octreotide |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [7] 67, 75, 84, 85, 89, 193, 227 💬 |
61 |
Omnitrope |
- |
- |
- |
- |
078 [2] 78, 193 💬 |
62 |
Ot |
- |
- |
- |
- |
193 [1] 193 💬 |
63 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
64 |
Other: low dose (1 mcg) acth stimulation test |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
193 [1] 193 💬 |
65 |
Other: overnight metyrapone test |
Metyrapone |
[2] D00410 D00410, D05019 D05019 💬 |
CYP11B1 [1] CYP11B1 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
193 [1] 193 💬 |
66 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
67 |
Oxytocin |
Oxytocin |
[1] D00089 D00089 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
006 [5] 6 , 127, 193, 206, 226 💬 |
68 |
Oxytocin (oxt) continuous |
Oxytocin |
[1] D00089 D00089 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
69 |
Physiological serum (sodium chloride) |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
193 [1] 193 💬 |
70 |
Pitolisant |
Pitolisant |
[1] D10749 D10749 💬 |
HRH3 [1] HRH3 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [2] 6 , 193 💬 |
71 |
Pitolisant oral tablets |
Pitolisant |
[1] D10749 D10749 💬 |
HRH3 [1] HRH3 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
193 [1] 193 💬 |
72 |
Probiotic |
- |
- |
- |
- |
002 [7] 2 , 6 , 93, 96, 97, 193, 266 💬 |
73 |
Procedure: biopsy |
- |
- |
- |
- |
051 [3] 51, 78, 193 💬 |
74 |
Procedure: dexa, blood tests, h.g.p.o, osseous age. |
- |
- |
- |
- |
078 [2] 78, 193 💬 |
75 |
R05cb01 |
- |
- |
- |
- |
193 [1] 193 💬 |
76 |
Recombinant human growth hormon |
- |
- |
- |
- |
193 [1] 193 💬 |
77 |
Recombinant human growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [3] 78, 193, 265 💬 |
78 |
Recombinant human growth hormone (rhgh) injection |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
193 [1] 193 💬 |
79 |
Recombinant somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
193 [1] 193 💬 |
80 |
Rhgh |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
076 [4] 76, 78, 96, 193 💬 |
81 |
Rimonabant |
Rimonabant |
[1] D05731 D05731 💬 |
CNR1 [1] CNR1 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
193 [1] 193 💬 |
82 |
Rm-493 |
- |
- |
- |
- |
193 [2] 193, 202 💬 |
83 |
Sandostatin lar |
- |
- |
- |
- |
067 [4] 67, 84, 193, 227 💬 |
84 |
Saxenda |
- |
- |
- |
- |
193 [1] 193 💬 |
85 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
86 |
Somatropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [16] 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
87 |
Subcutaneous beloranib in suspension |
Beloranib |
- |
- |
- |
193 [1] 193 💬 |
88 |
Syntocinon |
- |
- |
- |
- |
006 [3] 6 , 127, 193 💬 |
89 |
Syntocinon nasal spray |
- |
- |
- |
- |
193 [1] 193 💬 |
90 |
Syntocinon®/- spray |
- |
- |
- |
- |
193 [1] 193 💬 |
91 |
Tesofensine |
Tesofensine |
- |
- |
- |
006 [2] 6 , 193 💬 |
92 |
Tesofensine/metoprolol |
Metoprolol |
[3] D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
193 [1] 193 💬 |
93 |
Topiramate |
Topiramate |
[1] D00537 D00537 💬 |
CA2 [36] CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [52] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 140, 144, 156, 193 💬 |
94 |
Zgn-440 |
- |
- |
- |
- |
193 [1] 193 💬 |
95 |
Zgn-440 for injectable suspension |
- |
- |
- |
- |
193 [1] 193 💬 |
96 |
Zgn-440 sterile diluent |
- |
- |
- |
- |
193 [1] 193 💬 |